BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12114193)

  • 41. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A; Merino P; Manrique LG; Ospina JP; Cheng L; Wu F; Jeanneret V; Yepes M
    J Neurosci; 2017 Oct; 37(43):10310-10322. PubMed ID: 28931568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
    de Paulis A; Montuori N; Prevete N; Fiorentino I; Rossi FW; Visconte V; Rossi G; Marone G; Ragno P
    J Immunol; 2004 Nov; 173(9):5739-48. PubMed ID: 15494526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.
    Bhandary YP; Velusamy T; Shetty P; Shetty RS; Idell S; Cines DB; Jain D; Bdeir K; Abraham E; Tsuruta Y; Shetty S
    Am J Respir Crit Care Med; 2009 Feb; 179(4):288-98. PubMed ID: 19029002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of urokinase expression at the posttranscription level by lung epithelial cells.
    Shetty SK; Marudamuthu AS; Abernathy D; Shetty RS; Shetty P; Fu J; Idell S; Bhandary YP; Ji H; Liu MC; Shetty S
    Biochemistry; 2012 Jan; 51(1):205-13. PubMed ID: 22166006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability.
    Shetty S
    Mol Cell Biochem; 2002 Aug; 237(1-2):55-67. PubMed ID: 12236587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism.
    Montuori N; Mattiello A; Mancini A; Santoli M; Taglialatela P; Caputi M; Rossi G; Ragno P
    FEBS Lett; 2001 Nov; 508(3):379-84. PubMed ID: 11728456
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells.
    Perkins RC; Broaddus VC; Shetty S; Hamilton S; Idell S
    Am J Respir Cell Mol Biol; 1999 Nov; 21(5):637-46. PubMed ID: 10536123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
    Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding.
    Quax PH; Grimbergen JM; Lansink M; Bakker AH; Blatter MC; Belin D; van Hinsbergh VW; Verheijen JH
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):693-701. PubMed ID: 9598826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation and role of urokinase plasminogen activator in vascular remodelling.
    Tkachuk V; Stepanova V; Little PJ; Bobik A
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, solution structure, and biological evaluation of urokinase type plasminogen activator (uPA)-derived receptor binding domain mimetics.
    Schmiedeberg N; Schmitt M; Rölz C; Truffault V; Sukopp M; Bürgle M; Wilhelm OG; Schmalix W; Magdolen V; Kessler H
    J Med Chem; 2002 Nov; 45(23):4984-94. PubMed ID: 12408709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor.
    Shetty S; Kumar A; Johnson AR; Idell S
    Antisense Res Dev; 1995; 5(4):307-14. PubMed ID: 8746780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.
    Chu EK; Cheng J; Foley JS; Mecham BH; Owen CA; Haley KJ; Mariani TJ; Kohane IS; Tschumperlin DJ; Drazen JM
    Am J Respir Cell Mol Biol; 2006 Dec; 35(6):628-38. PubMed ID: 16794260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Domain-dependent action of urokinase on smooth muscle cell responses.
    Tanski WJ; Fegley AJ; Roztocil E; Davies MG
    J Vasc Surg; 2004 Jan; 39(1):214-22. PubMed ID: 14718842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A competitive chromogenic assay to study the functional interaction of urokinase-type plasminogen activator with its receptor.
    Rettenberger P; Wilhelm O; Oi H; Weidle UH; Goretzki L; Koppitz M; Lottspeich F; König B; Pessara U; Kramer MD
    Biol Chem Hoppe Seyler; 1995 Oct; 376(10):587-94. PubMed ID: 8590627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
    Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Occupancy of the cancer cell urokinase receptor (uPAR): effects of acid elution and exogenous uPA on cell surface urokinase (uPA).
    Baker MS; Liang XM; Doe WF
    Biochim Biophys Acta; 1992 Sep; 1117(2):143-52. PubMed ID: 1381963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.